Cryo-Cell wins NYSE American compliance plan, avoids delisting through Sept. 9, 2027

Cryo-Cell International, Inc.

Cryo-Cell International, Inc.

CCEL

0.00
  • Cryo-Cell flagged by NYSE American for failing continued listing standards under Section 1003(a), tied to a stockholders’ deficit as of Nov. 30, 2025, alongside net losses in two of three fiscal years ended Nov. 30, 2023, Nov. 30, 2024, Nov. 30, 2025.
  • Exchange accepted compliance plan submitted April 8, 2026, granting a remediation window through Sept. 9, 2027.
  • Common stock remains listed during plan period, subject to ongoing review and progress against plan milestones.
  • Failure to regain compliance by Sept. 9, 2027, or falling short of plan progress, could trigger delisting proceedings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605081600BIZWIRE_USPR_____20260508_BW258879) on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.